We are live on ! Find out more
WIC

Willis Investment Counsel Portfolio holdings

AUM $2.1B
1-Year Est. Return 24.61%
This Fund
S&P 500
This Quarter Est. Return
+9.62%
1 Year Est. Return
+24.61%
3 Year Est. Return
+53.31%
5 Year Est. Return
+71.06%
10 Year Est. Return
+1,214.29%
AUM
$1.9B
AUM Growth
+$149M
Cap. Flow
+$1.04M
Cap. Flow %
0.05%
Top 10 Hldgs %
27.59%
Holding
113
New
3
Increased
36
Reduced
61
Closed
4

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$8.71M
2
PAYX icon
Paychex
PAYX
+$5.97M
3
CVX icon
Chevron
CVX
+$5.78M
4
KMB icon
Kimberly-Clark
KMB
+$5.3M
5
FDS icon
Factset
FDS
+$4.84M

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Healthcare 14.67%
3 Financials 13.62%
4 Consumer Staples 12.91%
5 Industrials 12.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUR icon
76
Murphy Oil
MUR
$4.78B
$4.71M 0.25%
180,306
-88,411
-33% -$2.44M
HXL icon
77
Hexcel
HXL
$7.82B
$4.44M 0.23%
85,707
-25,064
-23% -$1.42M
META icon
78
Meta Platforms (Facebook)
META
$1.51T
$3.32M 0.17%
9,876
-139
-1% -$46.1K
FLR icon
79
Fluor
FLR
$7.96B
$3.05M 0.16%
123,231
-50,186
-29% -$1.07M
MEDP icon
80
Medpace
MEDP
$16.5B
$2.92M 0.15%
13,398
+45
+0.3% +$9.42K
STRL icon
81
Sterling Infrastructure
STRL
$16.7B
$2.6M 0.14%
98,871
-38,442
-28% -$989K
QLYS icon
82
Qualys
QLYS
$6.35B
$2.58M 0.14%
18,826
+12,922
+219% +$1.65M
APA icon
83
APA Corp
APA
$13.2B
$2.46M 0.13%
91,291
-90,682
-50% -$2.41M
ATKR icon
84
Atkore
ATKR
$3.16B
$2.39M 0.13%
21,519
-2,967
-12% -$301K
NRC icon
85
NRC Health Common Stock
NRC
$450M
$2.19M 0.12%
52,643
-3,563
-6% -$155K
EVTC icon
86
Evertec
EVTC
$1.78B
$2.09M 0.11%
41,765
+17,396
+71% +$805K
DCI icon
87
Donaldson
DCI
$11.4B
$1.85M 0.1%
31,205
-1,804
-5% -$107K
FIZZ icon
88
National Beverage
FIZZ
$3.01B
$1.82M 0.1%
40,051
+356
+0.9% +$19.4K
SEB icon
89
Seaboard Corp
SEB
$4.06B
$1.34M 0.07%
341
-164
-32% -$653K
BLBD icon
90
Blue Bird Corp
BLBD
$2.18B
$1.33M 0.07%
85,198
-23,067
-21% -$458K
CSGS
91
DELISTED
CSG Systems International
CSGS
$1.31M 0.07%
22,736
+15,034
+195% +$797K
GNRC icon
92
Generac Holdings
GNRC
$12.5B
$1.28M 0.07%
3,637
-1,164
-24% -$483K
AMPE
93
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$1.24M 0.07%
7,273
+500
+7% +$186K
FTDR icon
94
Frontdoor
FTDR
$6.26B
$1.01M 0.05%
27,675
-39,890
-59% -$1.51M
CDK
95
DELISTED
CDK Global, Inc.
CDK
$807K 0.04%
19,327
-1,118
-5% -$46.9K
KO icon
96
Coca-Cola
KO
$375B
$592K 0.03%
10,000
PATI
97
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$582K 0.03%
72,101
-21,143
-23% -$235K
OGN icon
98
Organon & Co
OGN
$3.57B
$489K 0.03%
+16,075
New +$524K
BRK.A icon
99
Berkshire Hathaway Class A
BRK.A
$1.12T
$451K 0.02%
1
DTD icon
100
WisdomTree US Total Dividend Fund
DTD
$1.69B
$412K 0.02%
6,366

Similar funds

Willis Investment Counsel's Q4 2021 Portfolio in Review

As of Q4 2021, Willis Investment Counsel held 113 positions worth $1.9B, up 8.5% from $1.75B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Willis Investment Counsel's Q4 2021 filing shows 3 new, 36 increased, 61 reduced and 4 closed positions. Its largest new stake was Darden Restaurants: 53,400 shares worth $8.04M. The largest sale was Pfizer, an estimated $8.71M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Willis Investment Counsel's largest Q4 2021 buy was Darden Restaurants: 53,400 shares worth $8.04M.
  • Willis Investment Counsel added most to Applied Materials in Q4 2021, an estimated $8.86M increase.
  • Willis Investment Counsel's biggest Q4 2021 reduction was Pfizer, cutting an estimated $8.71M.
  • Willis Investment Counsel fully exited Occidental Petroleum in Q4 2021, selling an estimated $3.25M.
  • Willis Investment Counsel's ten largest holdings make up 28% of its $1.9B portfolio in Q4 2021.
  • Willis Investment Counsel opened 3 new positions and closed 4 in Q4 2021.
  • Willis Investment Counsel's portfolio value rose 8.5% quarter-over-quarter to $1.9B.

Based on Willis Investment Counsel's 13F filing for Q4 2021, filed 14 Feb 2022.